Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Hall

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Cell Stem Cell|July 8, 2017
Muscle Stem Cells Undergo Extensive Clonal Drift during Tissue Growth via Meox1-Mediated Induction of G2 Cell-Cycle ArrestPhong Dang Nguyen, David Baruch Gurevich, Carmen Sonntag, et al.
Chemical Science|October 10, 2017
Full color palette of fluorescent d-amino acids for <i>in situ</i> labeling of bacterial cell wallsYen-Pang Hsu, Jonathan Rittichier, Erkin Kuru, et al.
Nature|August 15, 2014
Haematopoietic stem cell induction by somite-derived endothelial cells controlled by meox1Phong Dang Nguyen, Georgina Elizabeth Hollway, Carmen Sonntag, et al.
Journal of Medicinal Chemistry|August 12, 2021
Discovery and Toxicological Profiling of Aminopyridines as Orally Bioavailable Selective Inhibitors of PI3-Kinase γBenjamin R Bellenie, Edward Hall, Ian Bruce, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma"David A Sandham, Lucy Barker, Lyndon Brown, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of AsthmaDavid A Sandham, Lucy Barker, Lyndon Brown, et al.
Bioorganic & Medicinal Chemistry|September 12, 2013
Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseasesDavid A Sandham, Nicola Arnold, Heinrich Aschauer, et al.
Journal of Medicinal Chemistry|May 24, 2021
Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary DiseaseDarren Le Grand, Martin Gosling, Urs Baettig, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cell Stem Cell|July 8, 2017
Muscle Stem Cells Undergo Extensive Clonal Drift during Tissue Growth via Meox1-Mediated Induction of G2 Cell-Cycle ArrestPhong Dang Nguyen, David Baruch Gurevich, Carmen Sonntag, et al.
Chemical Science|October 10, 2017
Full color palette of fluorescent d-amino acids for <i>in situ</i> labeling of bacterial cell wallsYen-Pang Hsu, Jonathan Rittichier, Erkin Kuru, et al.
Nature|August 15, 2014
Haematopoietic stem cell induction by somite-derived endothelial cells controlled by meox1Phong Dang Nguyen, Georgina Elizabeth Hollway, Carmen Sonntag, et al.
Journal of Medicinal Chemistry|August 12, 2021
Discovery and Toxicological Profiling of Aminopyridines as Orally Bioavailable Selective Inhibitors of PI3-Kinase γBenjamin R Bellenie, Edward Hall, Ian Bruce, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma"David A Sandham, Lucy Barker, Lyndon Brown, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of AsthmaDavid A Sandham, Lucy Barker, Lyndon Brown, et al.
Bioorganic & Medicinal Chemistry|September 12, 2013
Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseasesDavid A Sandham, Nicola Arnold, Heinrich Aschauer, et al.
Journal of Medicinal Chemistry|May 24, 2021
Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary DiseaseDarren Le Grand, Martin Gosling, Urs Baettig, et al.
Pageof 3